oseen · source-linked reporting

The United States Federal Drug Administration approves Vertex Pharmaceuticals' new Journavx drug, a

2025 Potomac River mid-air collision — The United States Federal Drug Administration approves Vertex Pharmaceuticals' new Journavx drug, a non-opioid analgesic used to treat acute pain and potentially eliminate the risk

Published January 30, 2025· Updated October 28, 2026·1 min read

Context: 2025 Potomac River mid-air collision.

The United States Federal Drug Administration approves Vertex Pharmaceuticals' new Journavx drug, a non-opioid analgesic used to treat acute pain and potentially eliminate the risks of opioid addiction and overdose. [https://apnews.com/article/nonopioid-painkiller-fda-vertex-pharmaceuticals-b1dd4276fce3d88ff32e3062e95f408f (AP)] [https://www.fda.gov/news-events/press-announcements/fda-approves-novel-non-opioid-treatment-moderate-severe-acute-pain (FDA)]

Event summary via Wikipedia Current Events (2025-01-30).